Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome

Abstract

The aim of this study was to examine potential links between antiOxLDL antibodies and the clinical and biological features of secondary antiphospholipid syndrome (II APLS) associated with systemic lupus erythematosus (SLE).

A cohort study was done of 98 SLE patients followed-up for 1 y, including 18 with definite II APLS and 13 patients with definite primary APLS (I APLS). IgG anticardiolipin, IgG antib2 GPI, lupus anticoagulant, VDRL and IgG antiOxLDL were measured in all 98 study subjects.

High antiOxLDL titers were found in seven (39%) of the 18 patients with II APLS vs 10 (12.5%) of the 80 patients without APLS (P < 0.01; OR ‘ 4.45; 95% CI = 1.4–14.1) and none of the 13 patients with I APLS (P < 0.02). The mean antiOxLDL titer was not significantly higher in the SLE patients with than without II APLS (P > 0.05). A high antiOxLDL titer was correlated with deep venous thrombosis (P < 0.01; OR = 5.77; 95% CI = 0.54–61) but not with arterial thrombosis (P > 0.05; OR = 1; 95% CI = 0.29–3.09), thrombocytopenia, central nervous system involvement, livedo reticularis, or a positive Coombs test. The antiOxLDL antibody titer was correlated with the IgG anticardiolipin antibody titer (r = 0.235; P = 0.02) and with the IgG anti-b2 GPI antibody titer (r = 0.224; P = 0.026).

AntiOxLDL elevation was found in 17% of SLE patients and was significantly associated with II APLS and venous thrombosis. We found no evidence suggesting that antiOxLDL may be associated with atherosclerosis.

Keywords

OxLDL antibody antiphospholipid syndrome SLE venous thrombosis atherosclerosis

Get full access to this article

View all access options for this article.

References

Palinski WW , Yla-Herttuala S , Rosenfeld ME et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein . Arteriosclerosis 1990; 10: 325–335 .

Salonen JT , Yla-Herttuala S , Yamamoto R et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis . Lancet 1992; 339: 883–887 .

Puurunen M , Manttari M , Manninen V et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction . Arch Intern Med 1994; 154: 2605–2609 .

Ryan M , Owens D , Kilbride B , Collins P , Johnson A , Tomkin GH . Antibodies to oxidized lipoproteins and their relationship to myocardial infarction . Q J Med 1998; 91: 411–415 .

Vaarala O , Alfthan G , Jauhiainen M , Leirisalo-Repo M , Aho K , Palosuo T . Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus (SLE) . Lancet 1993; 341: 923–925 .

Bellomo G , Maggi E , Poli M , Agosta FG , Bollati P , Finardi G . Autoantibodies against oxidatively-modified low density lipoproteins in non insulin dependent diabetes mellitus . Diabetes 1995; 44: 60–66 .

Tazber F , Esterbauer H . Autoantibodies to oxidized low density lipoprotein . Free Radicals Lipoprotein Oxidation Atheroscler 1999; 9: 245–262 .

Amengual O , Atsumi T , Khamashta MA , Tinahones F , Hughes GRV . Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome . Br J Rheumatol 1997; 36: 964–968 .

Cuadrado MJ , Tinahones F , Camps MT et al. Antiphospholipid, anti-b2-glycoprotein-I and anti-oxidized–low-density-lipoprotein antibodies in antiphospholipid syndrome . Q J Med 1998; 91: 619–612 .

10.

Aho K , Vaarala O , Tenkanen L et al. Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosus . Clin Exp Rheumatol 1996; 14: 499–506 .

11.

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 42: 1309–1311 .

12.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

13.

Brandt JT , Triplett DA . Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH . Thrombosis Haemost 1995; 74: 1185–1190 .

14.

Parums DV , Brown DL , Mitchinson MJ . Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis . Arch Pathol Lab Med 1990; 114: 383–387 .

15.

Chiesa R , Melissano G , Castellano R et al. In search of biological markers of high-risk carotid artery atherosclerotic plaque: enhanced LDL oxidation . Ann Vasc Surg 1998; 12: 1–9 .

16.

Tazber F, Lapin A, Temmel CH, Wonisch W. Antibodies against oxidized LDL (oLAb) in Viennese working people. Austrian Soc Allergy Immunol 1995, poster presentation.

17.

Urowitz MB , Gladman DD . Accelerated atheroma in lupus <Eth> background . Lupus 2000; 9: 161–165 .

18.

Vaarala O , Puurunen M , Lukka M et al. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein . Clin Exp Immunol 1996; 104: 268–274 .

19.

Horkko S , Miller E , Dud L et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein . J Clin Invest 1996; 98: 815–825 .

20.

Wu R , Svenungsson E , Gunnarson I et al. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and b2-glycoprotein I (b2-GPI) in systemic lupus erythematosus . Clin Exp Immunol 1999; 115: 561–566 .

21.

Romero FI , Amengual O , Atsumi T , Khamashta MA , Tinahones FJ , Hughes GRV . Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein . Br J Rheumatol 1998; 37: 883–888 .

22.

Tinahones FJ , Cuadrado MJ , Khamashta MA et al. Lack of crossreaction between antibodies to b2-glycoprotein-I and oxidized lowdensity lipoprotein in patients with antiphospholipid syndrome . Br J Rheumatol 1998; 37: 746–749 .

23.

Tubach F , Hayem G , Marchand JL et al. IgG anti-beta2 GPI antibodies in adult patients with SLE: prevalence and diagnostic value for antiphospholipid syndrome . J Rheumatol 2000; 27: 1437–1443 .